Face Masks for Preventing Influenza Transmission
NCT00774774 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 372
Last updated 2011-04-26
Summary
This work aims to measure the effectiveness of face mask worn by a patient with flu to avoid transmission to other persons in the household.
Conditions
- Influenza Human
Interventions
- DEVICE
-
control
Non sterile surgical mask,high filtration "AEROKYN",type 2 with eardrop
- DEVICE
-
Face mask
Non sterile surgical mask, high filtration "AEROKYN", type 2 with eardrop Masks will be worn at home by the patient over a period of 5 days following inclusion, whenever a member of the household will attend the same room or in other confined space (eg car), and changed after 3 hours of consecutive use or sooner if they are tor Masks will not be worn: * during the night, * when the patient is alone in the room. Moreover, for all households, an incentive in nocturnal isolation of index-patient will be recommended
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Fabrice CARRAT, MD PhD · Assistance Publique - Hôpitaux de Paris
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2009-09-30
- Completion
- 2009-09-30
Countries
- France
Study Locations
More Related Trials
-
A Randomised Controlled Trial on the Effect of Post-exposure Oseltamivir Prophylaxis on Influenza Transmission in Nursing Homes
NCT01053377 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated With Experimental Influenza Virus (MK-4482-019)
NCT05818124 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 2B Study on Safety and Therapeutic Efficacy of DAS181 in Adult Subjects With Naturally Acquired Influenza
NCT01740063 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Oseltamivir Treatment on the Yield of Polymerase Chain Reaction Test for Confirmed Influenza Infection
NCT02334514 ·Status: COMPLETED
-
Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.
NCT00419263 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection
NCT03376321 ·Status: TERMINATED ·Phase: PHASE3
-
Testing the AVI-7100 Flu Drug in Healthy Volunteers
NCT01747148 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A
NCT05567783 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of MHAA4549A in Healthy Volunteers in an Influenza Challenge Model
NCT01980966 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study on the Safety and Efficacy of GP681 Tablets in the Treatment of Uncomplicated Acute Influenza
NCT04736758 ·Status: COMPLETED ·Phase: PHASE2
-
The Chloroquine for Influenza Prevention Trial
NCT01078779 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults
NCT04250311 ·Status: SUSPENDED ·Phase: PHASE3
-
A Study of Oseltamivir (Tamiflu) for the Seasonal Prophylaxis of Influenza in Immunocompromised Participants
NCT00412737 ·Status: COMPLETED ·Phase: PHASE4
-
Statin Therapy in Acute Influenza
NCT02056340 ·Status: COMPLETED ·Phase: PHASE2
-
Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus
NCT04344379 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Efficacity and Safety of Oseltamivir and Zanamivir
NCT00799760 ·Status: TERMINATED ·Phase: PHASE3
-
Convalescent Plasma to Limit SARS-CoV-2 Associated Complications
NCT04373460 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness
NCT04610047 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.
NCT01224795 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of MHAA4549A in Combination With Oseltamivir Versus Oseltamivir in Participants With Severe Influenza A Infection
NCT02293863 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections
NCT05269290 ·Status: COMPLETED ·Phase: PHASE3
-
Study of ZSP1273 in Patients With Acute Uncomplicated Influenza A
NCT04024137 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for Influenza
NCT01227798 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza
NCT00453999 ·Status: COMPLETED ·Phase: PHASE2
-
Immunomodulatory Effect of Macrolides in Naturally Occurring Influenza Virus Infections in the Community
NCT03824847 ·Status: SUSPENDED ·Phase: PHASE4